PANews reported on January 30th that tokenization infrastructure provider Securitize submitted a public registration statement with the SEC, aiming to go public through a merger with Cantor Equity Partners II, a blank check company backed by Cantor Fitzgerald. According to the filing, the company generated revenue of $55.60 million in the first nine months of 2025—a remarkable 841.00% surge compared to the same period in 2024. Moreover, its full-year 2024 revenue reached $18.80 million, more than doubling the 2023 figures. Interestingly, while crypto and related stocks largely fell 5.00%-10.00% that day, CEPT's stock bucked the trend and closed up 4.40%, suggesting investors remain quite bullish on this tokenization opportunity despite broader market headwinds.
PANews reported on January 30th that, according to CoinDesk, tokenization infrastructure company Securitize has filed a public registration statement with the U.S. Securities and Exchange Commission (SEC) to advance its plan to go public through a merger with Cantor Equity Partners II, a blank check company backed by Cantor Fitzgerald. The filing shows that the company achieved revenue of $55.6 million in the first nine months of 2025, a significant increase of 841% compared to the same period in 2024. Its full-year revenue in 2024 was $18.8 million, more than double that of 2023. While cryptocurrency and related stocks generally fell by 5%-10% that day, CEPT's stock price bucked the trend, closing up 4.4%.
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.